BRIEF published on 05/31/2024 at 07:05, 1 year 6 months ago SKAN Increases Stake in Aseptic Technologies to 90 Percent Pharmaceutical Industry Stake Increase SKAN Aseptic Technologies AT-Closed Vial®
PRESS RELEASE published on 05/31/2024 at 07:00, 1 year 6 months ago SKAN increases stake in Aseptic Technologies to 90 percent SKAN Group AG increases its stake in Aseptic Technologies to 90%, reinforcing strategic importance. Aseptic Technologies specializes in AT-Closed Vial® Technology for cell and gene therapy applications Pharmaceutical Industry Stake Increase SKAN Group AG Aseptic Technologies AT-Closed Vial® Technology
BRIEF published on 05/07/2024 at 18:05, 1 year 6 months ago SKAN Group AG's Annual General Meeting: Unanimous Approval of Proposals, Beat Lüthi Elected Chairman Annual General Meeting Shareholder Approval Dividend SKAN Group AG Chairman Election
PRESS RELEASE published on 05/07/2024 at 18:00, 1 year 6 months ago Annual General Meeting of SKAN Group AG approves all pro-posals and elects Beat Lüthi as Chairman SKAN AG Annual General Meeting approves all proposals and elects Beat Lüthi as Chairman. Distribution of CHF 0.35 dividend per share approved, next AGM on 5 May 2025 Board Of Directors Annual General Meeting Dividend Distribution SKAN AG Beat Lüthi
BRIEF published on 03/26/2024 at 07:05, 1 year 8 months ago SKAN Group Announces Strong Financial Performance in 2023 with Increased Sales and Margins Financial Performance EBITDA Margin Biopharmaceutical Industry Annual Report 2023 SKAN Group
PRESS RELEASE published on 03/26/2024 at 07:00, 1 year 8 months ago SKAN with higher sales and margin in 2023 SKAN Group AG achieved higher sales and margin in 2023, exceeding communicated financial targets. Strategic initiatives on track with positive outlook for 2024 2023 Strategic Initiatives SKAN Group AG Higher Sales Margin
PRESS RELEASE published on 08/22/2023 at 07:00, 2 years 3 months ago SKAN Group demonstrates operational strength
PRESS RELEASE published on 05/26/2023 at 17:45, 2 years 6 months ago SKAN Group AG informs about the ongoing investigation of the Office of the Attorney General of Switzerland
PRESS RELEASE published on 05/25/2023 at 07:00, 2 years 6 months ago Statement of SKAN Group AG on an investigation by the Office of the Attorney General of Switzerland
PRESS RELEASE published on 05/03/2023 at 18:52, 2 years 7 months ago Annual General Meeting of SKAN Group AG approves all proposals
Published on 12/05/2025 at 02:35, 7 hours 10 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 45 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 40 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 45 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:30, 15 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 40 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 45 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 1 minute ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health